Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: results of a randomized trial
In a 12-month, multicenter, open-label study, 106 children were randomized at 4 to 6 weeks after kidney transplantation to switch to everolimus with reduced TAC (EVR/rTAC) and steroid elimination from month 5 posttransplant or to continue standard tacrolimus with mycophenolate mofetil (sTAC/MMF) and...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
American journal of transplantation
Year: 2018, Jahrgang: 19, Heft: 3, Pages: 811-822 |
| ISSN: | 1600-6143 |
| DOI: | 10.1111/ajt.15081 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1111/ajt.15081
|
| Verfasserangaben: | Burkhard Toenshoff, Robert Ettenger, Luca Dello Strologo, Stephen D. Marks, Lars Pape, Helio Tedesco-Silva Jr, Anna Bjerre, Martin Christian, Matthias Meier, El-Djouher Martzloff, Barbara Rauer, Jennifer Ng, Patricia Lopez |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662803168 | ||
| 003 | DE-627 | ||
| 005 | 20230426154241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190404r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ajt.15081 |2 doi | |
| 035 | |a (DE-627)1662803168 | ||
| 035 | |a (DE-599)KXP1662803168 | ||
| 035 | |a (OCoLC)1341207880 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Tönshoff, Burkhard |e VerfasserIn |0 (DE-588)1032445823 |0 (DE-627)738463493 |0 (DE-576)173494196 |4 aut | |
| 245 | 1 | 0 | |a Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination |b results of a randomized trial |c Burkhard Toenshoff, Robert Ettenger, Luca Dello Strologo, Stephen D. Marks, Lars Pape, Helio Tedesco-Silva Jr, Anna Bjerre, Martin Christian, Matthias Meier, El-Djouher Martzloff, Barbara Rauer, Jennifer Ng, Patricia Lopez |
| 264 | 1 | |c 2019 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 20 August 2018 | ||
| 500 | |a Gesehen am 04.04.2019 | ||
| 520 | |a In a 12-month, multicenter, open-label study, 106 children were randomized at 4 to 6 weeks after kidney transplantation to switch to everolimus with reduced TAC (EVR/rTAC) and steroid elimination from month 5 posttransplant or to continue standard tacrolimus with mycophenolate mofetil (sTAC/MMF) and steroids. The cumulative incidence of a co-primary efficacy end point (biopsy-proven acute rejection [BPAR], graft loss, or death from randomization to month 12) was 10.3% with EVR/rTAC and 5.8% with sTAC/MMF (difference 4.4%; P = .417). BPAR occurred in 9.6% and 5.6% of patients, respectively. Patient and renal allograft survival were 100%. The co-primary end point of mean estimated glomerular filtration rate at month 12 was 76.2 mL/min/1.73 m(2) with EVR/rTAC and 72.5 mL/min/1.73 m(2) for sTAC/MMF (difference 3.8 mL/min/1.73m(2); P = .49). One EVR/rTAC patient developed posttransplant lymphoproliferative disease. Longitudinal growth and sexual maturation were equivalent between groups. The randomized drug regimen was discontinued in 34.6% and 13% of patients in the EVR/rTAC and sTAC/MMF groups, respectively (P = .024), and discontinued due to adverse events/infections in 25.0% and 11.1% of patients (P = .062). In conclusion, early conversion of pediatric kidney transplant patients from TAC, MMF, and steroids to EVR/rTAC and steroid withdrawal maintains immunosuppressive efficacy and preserves renal function. | ||
| 534 | |c 2018 | ||
| 650 | 4 | |a calcineurin inhibitor therapy | |
| 650 | 4 | |a children | |
| 650 | 4 | |a clinical research/practice | |
| 650 | 4 | |a de-novo therapy | |
| 650 | 4 | |a efficacy | |
| 650 | 4 | |a immunosuppressant-calcineurin inhibitor: tacrolimus | |
| 650 | 4 | |a immunosuppressant-mechanistic target of rapamycin: everolimus | |
| 650 | 4 | |a immunosuppressive regimens-minimization/withdrawal | |
| 650 | 4 | |a kidney transplantation/nephrology | |
| 650 | 4 | |a low-dose cyclosporine | |
| 650 | 4 | |a mammalian target | |
| 650 | 4 | |a multicenter | |
| 650 | 4 | |a pediatrics | |
| 650 | 4 | |a rapamycin inhibitors | |
| 650 | 4 | |a recipients | |
| 650 | 4 | |a sparing regimens | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of transplantation |d [Amsterdam] : Elsevier, 2001 |g 19(2019), 3, Seite 811-822 |h Online-Ressource |w (DE-627)328318353 |w (DE-600)2045621-9 |w (DE-576)094404267 |x 1600-6143 |7 nnas |a Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination results of a randomized trial |
| 773 | 1 | 8 | |g volume:19 |g year:2019 |g number:3 |g pages:811-822 |g extent:12 |a Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination results of a randomized trial |
| 856 | 4 | 0 | |u https://doi.org/10.1111/ajt.15081 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190404 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1032445823 |a Tönshoff, Burkhard |m 1032445823:Tönshoff, Burkhard |d 910000 |d 910500 |e 910000PT1032445823 |e 910500PT1032445823 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1662803168 |e 3418059899 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","display":"Tönshoff, Burkhard","roleDisplay":"VerfasserIn","given":"Burkhard","family":"Tönshoff"}],"title":[{"subtitle":"results of a randomized trial","title":"Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination","title_sort":"Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination"}],"language":["eng"],"recId":"1662803168","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["First published: 20 August 2018","Gesehen am 04.04.2019"],"name":{"displayForm":["Burkhard Toenshoff, Robert Ettenger, Luca Dello Strologo, Stephen D. Marks, Lars Pape, Helio Tedesco-Silva Jr, Anna Bjerre, Martin Christian, Matthias Meier, El-Djouher Martzloff, Barbara Rauer, Jennifer Ng, Patricia Lopez"]},"id":{"eki":["1662803168"],"doi":["10.1111/ajt.15081"]},"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"relHost":[{"pubHistory":["1.2001 -"],"part":{"extent":"12","text":"19(2019), 3, Seite 811-822","volume":"19","pages":"811-822","issue":"3","year":"2019"},"note":["Gesehen am 16.06.25"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination results of a randomized trialAmerican journal of transplantation","recId":"328318353","language":["eng"],"title":[{"title_sort":"American journal of transplantation","title":"American journal of transplantation","subtitle":"official journal of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST)"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"[Amsterdam] ; Copenhagen ; Oxford [u.a.] ; Oxford [u.a.]","publisher":"Elsevier ; Munksgaard ; Blackwell ; Wiley-Blackwell","dateIssuedKey":"2001","dateIssuedDisp":"2001-"}],"id":{"issn":["1600-6143"],"zdb":["2045621-9"],"eki":["328318353"],"doi":["10.1111/(ISSN)1600-6143"]}}],"physDesc":[{"extent":"12 S."}]} | ||
| SRT | |a TOENSHOFFBEARLYCONVE2019 | ||